Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

CXXC5 (retinoid-inducible nuclear factor, RINF) is a potential therapeutic target in high-risk human acute myeloid leukemia.

Astori A, Fredly H, Aloysius TA, Bullinger L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher C, Dusanter-Fourt I, Knappskog S, Lillehaug JR, Pendino F, Bruserud Ø.

Oncotarget. 2013 Sep;4(9):1438-48.

PMID:
23988457
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Activation of both protein kinase A (PKA) type I and PKA type II isozymes is required for retinoid-induced maturation of acute promyelocytic leukemia cells.

Nguyen E, Gausdal G, Varennes J, Pendino F, Lanotte M, Døskeland SO, Ségal-Bendirdjian E.

Mol Pharmacol. 2013 May;83(5):1057-65. doi: 10.1124/mol.112.081034. Epub 2013 Mar 1.

PMID:
23455313
[PubMed - indexed for MEDLINE]
Free Article
3.

Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.

Gausdal G, Wergeland A, Skavland J, Nguyen E, Pendino F, Rouhee N, McCormack E, Herfindal L, Kleppe R, Havemann U, Schwede F, Bruserud O, Gjertsen BT, Lanotte M, Ségal-Bendirdjian E, Døskeland SO.

Cell Death Dis. 2013 Feb 28;4:e516. doi: 10.1038/cddis.2013.39.

PMID:
23449452
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.

Samy M, Gattolliat CH, Pendino F, Hillion J, Nguyen E, Bombard S, Douc-Rasy S, Bénard J, Ségal-Bendirdjian E.

Mol Cancer Ther. 2012 Nov;11(11):2384-93. doi: 10.1158/1535-7163.MCT-12-0281. Epub 2012 Aug 28.

PMID:
22933702
[PubMed - indexed for MEDLINE]
Free Article
5.

Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.

Pronier E, Almire C, Mokrani H, Vasanthakumar A, Simon A, da Costa Reis Monte Mor B, Massé A, Le Couédic JP, Pendino F, Carbonne B, Larghero J, Ravanat JL, Casadevall N, Bernard OA, Droin N, Solary E, Godley LA, Vainchenker W, Plo I, Delhommeau F.

Blood. 2011 Sep 1;118(9):2551-5. doi: 10.1182/blood-2010-12-324707. Epub 2011 Jul 6.

PMID:
21734233
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

hTERT promotes imatinib resistance in chronic myeloid leukemia cells: therapeutic implications.

Deville L, Hillion J, Pendino F, Samy M, Nguyen E, Ségal-Bendirdjian E.

Mol Cancer Ther. 2011 May;10(5):711-9. doi: 10.1158/1535-7163.MCT-10-0979. Epub 2011 Mar 1.

PMID:
21364010
[PubMed - indexed for MEDLINE]
Free Article
7.

RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer.

Knappskog S, Myklebust LM, Busch C, Aloysius T, Varhaug JE, Lønning PE, Lillehaug JR, Pendino F.

Ann Oncol. 2011 Oct;22(10):2208-15. doi: 10.1093/annonc/mdq737. Epub 2011 Feb 16.

PMID:
21325450
[PubMed - indexed for MEDLINE]
Free Article
8.

Functional involvement of RINF, retinoid-inducible nuclear factor (CXXC5), in normal and tumoral human myelopoiesis.

Pendino F, Nguyen E, Jonassen I, Dysvik B, Azouz A, Lanotte M, Ségal-Bendirdjian E, Lillehaug JR.

Blood. 2009 Apr 2;113(14):3172-81. doi: 10.1182/blood-2008-07-170035. Epub 2009 Jan 30.

PMID:
19182210
[PubMed - indexed for MEDLINE]
Free Article
9.

LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.

Huang TS, Myklebust LM, Kjarland E, Gjertsen BT, Pendino F, Bruserud Ø, Døskeland SO, Lillehaug JR.

Mol Cancer. 2007 Apr 23;6:31.

PMID:
17451600
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths.

Wu YL, Dudognon C, Nguyen E, Hillion J, Pendino F, Tarkanyi I, Aradi J, Lanotte M, Tong JH, Chen GQ, Ségal-Bendirdjian E.

J Cell Sci. 2006 Jul 1;119(Pt 13):2797-806. Epub 2006 Jun 13.

PMID:
16772337
[PubMed - indexed for MEDLINE]
Free Article
11.

Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.

Arnesen T, Betts MJ, Pendino F, Liberles DA, Anderson D, Caro J, Kong X, Varhaug JE, Lillehaug JR.

BMC Biochem. 2006 Apr 25;7:13.

PMID:
16638120
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Telomeres and telomerase: Pharmacological targets for new anticancer strategies?

Pendino F, Tarkanyi I, Dudognon C, Hillion J, Lanotte M, Aradi J, Ségal-Bendirdjian E.

Curr Cancer Drug Targets. 2006 Mar;6(2):147-80. Review.

PMID:
16529544
[PubMed - indexed for MEDLINE]
13.

Induction of apoptosis in human cells by RNAi-mediated knockdown of hARD1 and NATH, components of the protein N-alpha-acetyltransferase complex.

Arnesen T, Gromyko D, Pendino F, Ryningen A, Varhaug JE, Lillehaug JR.

Oncogene. 2006 Jul 20;25(31):4350-60. Epub 2006 Mar 6.

PMID:
16518407
[PubMed - indexed for MEDLINE]
14.

Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.

Pendino F, Hillion J, Dudognon C, Delaunay J, Mourah S, Podgorniak MP, Lafon I, Chomienne C, Lanotte M, Dombret H, Rousselot P, Ségal-Bendirdjian E.

Leukemia. 2006 Apr;20(4):599-603.

PMID:
16482212
[PubMed - indexed for MEDLINE]
15.

Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death.

Tarkanyi I, Dudognon C, Hillion J, Pendino F, Lanotte M, Aradi J, Ségal-Bendirdjian E.

Leukemia. 2005 Oct;19(10):1806-11.

PMID:
16107885
[PubMed - indexed for MEDLINE]
16.

Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.

Dudognon C, Pendino F, Hillion J, Saumet A, Lanotte M, Ségal-Bendirdjian E.

Oncogene. 2004 Sep 30;23(45):7469-74.

PMID:
15326479
[PubMed - indexed for MEDLINE]
17.

Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.

Pendino F, Dudognon C, Delhommeau F, Sahraoui T, Flexor M, Bennaceur-Griscelli A, Lanotte M, Ségal-Bendirdjian E.

Oncogene. 2003 Dec 11;22(57):9142-50.

PMID:
14668795
[PubMed - indexed for MEDLINE]
18.

A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.

Pendino F, Sahraoui T, Lanotte M, Ségal-Bendirdjian E.

Leukemia. 2002 May;16(5):826-32.

PMID:
11986943
[PubMed - indexed for MEDLINE]
Free Article
19.

Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation.

Benoit G, Roussel M, Pendino F, Ségal-Bendirdjian E, Lanotte M.

Oncogene. 2001 Oct 29;20(49):7161-77. Review.

PMID:
11704845
[PubMed - indexed for MEDLINE]
Free Article
20.

Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.

Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E.

Proc Natl Acad Sci U S A. 2001 Jun 5;98(12):6662-7. Epub 2001 May 22.

PMID:
11371621
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk